About: Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 25 July 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xunetu de 2019 (ast) наукова стаття, опублікована 25 липня 2019 (uk) scientific article published on 25 July 2019 (en)
publication date	wds:Q92354578-A6887D88-08BB-4965-930B-6922F4BEBD6C
publication date	2019-07-25 00:00:00Z (xsd:dateTime)
cites work	wds:Q92354578-0A0C423B-9EAF-431A-87E5-16EB19C57C19 wds:Q92354578-174EAF4F-ABBE-4449-B64E-B353AB451602 wds:Q92354578-1991AC88-760E-442C-94DA-A212ED2A5F51 wds:Q92354578-1DD06D86-7B04-49E0-A783-A7922041B5CF wds:Q92354578-1DEC64F7-BF8A-4830-B0B0-9F51CC236D31 wds:Q92354578-3480FAE8-1625-4B97-8997-C96EDCB5863D wds:Q92354578-3A85DA7F-43B5-45BE-8B70-7D06FD916389 wds:Q92354578-40C3D667-467E-4399-915E-5A2B63919F4C wds:Q92354578-44373B90-398F-4A1F-B1B2-4EA9221B502D wds:Q92354578-46C71120-301B-4F08-B33D-2CB8999D0160 wds:Q92354578-4F7E00BD-F8CF-4F97-A337-D494E5CB3690 wds:Q92354578-510EFA61-588F-4A65-AD8B-C28EE84C307E wds:Q92354578-5301CDEC-B728-491F-ABAC-C3B7ADD40AED wds:Q92354578-5951EEB1-F3A8-401D-B464-3A0C2BCD2B99 wds:Q92354578-60A87D66-9497-4ADB-816E-62D21C6F2271 wds:Q92354578-610FF2EF-7C15-4897-BFED-4DC9E3725F37 wds:Q92354578-754F5D8D-E35B-4EC7-A093-E230B0B8D46D wds:Q92354578-773472C9-2C2A-498A-BA72-34354E3A87E6 wds:Q92354578-78523B5F-6CE6-4ADE-B83A-C61C974C98DD wds:Q92354578-7C1EC34B-AAA6-4217-8B74-AE67DFA500D1 wds:Q92354578-8ECE6556-15CD-4B03-9D8C-790464FADA41 wds:Q92354578-98815BEC-AEEC-4A24-BCC6-C2D7372AA6A3 wds:Q92354578-9C1FB1FA-7369-446E-8596-AB37431E0120 wds:Q92354578-CECA2C54-0A0B-40CA-A4C8-CD07951CB0A1 wds:Q92354578-D5CCC793-F9F4-44EB-8717-454BF2C4DF57 wds:Q92354578-E1E948EA-C8DD-4059-B7BD-066E7FD4A8C6 wds:Q92354578-F360CCA4-C820-4572-869A-6D28F8E4D727 wds:Q92354578-FAA64E90-64AE-4553-9860-07E1D72E56B5 wds:Q92354578-FB139F00-5B70-438F-BD82-7A3D9BC463BB wds:Q92354578-FB7BF4CE-5FA0-4FA9-8902-6D9C00C4CB95 wds:Q92354578-FFAE19CB-32B8-43AA-8004-C66E049C6A3A
cites work	Efficacy and safety of cefepime: a systematic review and meta-analysis Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis SHEA/APIC Guideline: Infection prevention and control in the long-term care facility Lack of development of new antimicrobial drugs: a potential serious threat to public health. Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society Mechanism of Cephalosporin-induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan. Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro Characteristics Noninferiority Trials: Is a New Treatment Almost as Effective as Another? In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms. Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study Laboratory diagnosis of pneumonia in the molecular age. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection Rejuvenate Taiwan: Time to act now: Strategies of fewer children and population aging in Taiwan. Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model
author name string	wds:Q92354578-084140BB-664E-4512-88E4-B9D6E34B8EA9 wds:Q92354578-66CCC584-E256-49AD-998D-BE8CC7D580CE wds:Q92354578-7067200C-E8DB-4D8B-A382-10BD5914E6D6 wds:Q92354578-9020C796-129E-47AF-A7B2-347162F445EF wds:Q92354578-9882929D-79E5-44B0-8A30-351995B00DA5 wds:Q92354578-AE995319-AACE-4353-B46C-5D6DD8335139 wds:Q92354578-AEF052D2-BE33-4EE7-977A-592BBFFDE86E wds:Q92354578-BDA6AEB0-C719-460B-956F-53BB289D62BC wds:Q92354578-ED34E246-F9CF-40CF-8C86-4595B06887B7 wds:Q92354578-EE264A0C-FA6E-4BD8-A3C1-C5AD92DFCF43 wds:Q92354578-F1B89769-CBBB-4FD3-9F71-5FDFEA44E66C wds:Q92354578-FD9FE816-EEC1-4F55-8B41-9919BB3B362D
author name string	Yen-Hsu Chen Jien-Wei Liu Yao-Shen Chen Jung-Chung Lin Min-Chi Lu Yung-Ching Liu Wen-Chien Ko Wen-Sen Lee Hung-Jen Tang Ching-Tai Huang Hsi-Hsun Lin Fu-Der Wang
rdfs:label	Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (en) Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (nl)
skos:prefLabel	Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (en) Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (nl)
name	Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (en) Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia (nl)
author	wds:Q92354578-9189426a-4939-2093-9c1b-aad03eb5706d

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software